News May 27, 2025 - Iolyx Therapeutics Announces Phase 2 Results for ILYX-002 in Autoimmune Dry Eye Disease WATCH a Webcast Replay of the Virtual R&D Update Event Led by KOLs March 12, 2025 - Iolyx Therapeutics to Present at Multiple Upcoming Ophthalmology Conferences
